Brazil green-lights Pfizer vaccine for kids 12 and up
Brazil’s health regulator approved the Pfizer COVID-19 vaccine Friday for use in children aged 12 and up, though they will likely have to wait months in line for older age
Brazil’s health regulator approved the Pfizer COVID-19 vaccine Friday for use in children aged 12 and up, though they will likely have to wait months in line for older age
Coronavirus cases continued to soar in Africa as they slowed elsewhere in the world for the sixth week in a row, throwing vaccine inequalities starkly into the spotlight.
The US Centers for Disease Control and Prevention (CDC) said Friday that emergency department visits for suspected suicide attempts by teenage girls rose significantly last year compared to 2019, highlighting
Indian start-up Mylab Discovery Solutions hopes that its inexpensive COVID-19 home test kit—the country’s first—will help the massive South Asian nation better track the pandemic’s spread among its 1.3-billion people.
Britain’s main doctors’ union has joined calls for the next planned lockdown easing in England to be delayed, as figures Friday showed new COVID-19 cases across the U.K. running at
U.S. regulators are allowing the release of about 10 million doses of Johnson & Johnson’s COVID-19 vaccine from a troubled Baltimore factory, but many more doses can’t be used and
An anticipated surge of tourism in Portugal is suddenly not at all certain — a symbol of the global economy’s continued struggle with pandemic uncertainty.
When restaurants closed to slow the spread of the coronavirus, the nationwide market for oysters cratered. That’s not the end of the story.
Concerns about crime are dominating the Democratic primary, and the party’s left wing has just started to coalesce.
The I.R.S. almost never audits private equity firms, even as whistle-blowers have filed claims alleging illegal tax avoidance.